MDNA - Medicenna Therapeutics Corp - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

MDNA is currently covered by 2 analysts with an average price target of $5.41. This is a potential upside of $5.1 (1645.16%) from yesterday's end of day stock price of $0.31.

Medicenna Therapeutics Corp's activity chart (see below) currently has 4 price targets and 10 ratings on display. The stock rating distribution of MDNA is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for MDNA is $2.5, Lowest price target is $2.5, average price target is $5.41.

Most recent stock forecast was given by MATTHEW BIEGLER from OPPENHEIMER on 14-Aug-2023. First documented stock forecast 10-Sep-2020.

Best performing analysts who are covering MDNA - Medicenna Therapeutics Corp:

Swayampakula Ramakanth Matthew Biegler

Currently out of the existing stock ratings of MDNA, 7 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

2.5

$2.19 (706.45%)

2.5

9 months 27 days ago

0/7 (0%)

$2 (400.00%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MDNA (Medicenna Therapeutics Corp) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on MDNA (Medicenna Therapeutics Corp) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the current lower performing score on MDNA (Medicenna Therapeutics Corp) with a proven track record?

MATTHEW BIEGLER

Which analyst has the most public recommendations on MDNA (Medicenna Therapeutics Corp)?

Swayampakula Ramakanth has 4 price targets and 3 ratings on MDNA

Which analyst is the currently most bullish on MDNA (Medicenna Therapeutics Corp)?

Swayampakula Ramakanth with highest potential upside - $2.19

Which analyst is the currently most reserved on MDNA (Medicenna Therapeutics Corp)?

Matthew Biegler with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?